![Andy Claude](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Andy Claude worked as Vice President-Finance at HUYA Bioscience International LLC from 2015 to 2017.
Prior to that, he obtained an undergraduate degree from the University of Nevada.
Former positions of Andy Claude
Companies | Position | End |
---|---|---|
HUYA Bioscience International LLC
![]() HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 30/04/2017 |
Training of Andy Claude
University of Nevada | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
HUYA Bioscience International LLC
![]() HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Andy Claude